Search
Now showing items 1-10 of 836
Sex differences in the clinical presentation and therapy of multiple sclerosis / Polne razlike u kliničkoj slici i terapiji multiple skleroze
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
Multiple sclerosis (MS) is more prevalent in women than in men, with the female to male ratio in the prevalence of MS constantly increasing. Besides, sex appears to affect the development, progression, clinical manifestation ...
Development and validation of a stability- indicating RP-HPLC method for determination of aripiprazole and its degradation products / Razvoj i validacija RP-HPLC metode za praćenje stabilnosti u cilju određivanja sadržaja aripiprazola i njegovih degradacionih proizvoda
(Savez farmaceutskih udruženja Srbije (SFUS), 2023)
The goal of this study was the optimization of chromatographic conditions and validation
of the isocratic RP-HPLC method for monitoring the stability of aripiprazole, identification and
quantitative analysis of aripiprazole ...
Novel pharmaceutical dosage forms of analgesics / Savremeni farmaceutski oblici analgetika
(Savez farmaceutskih udruženja Srbije, Beograd, 2019)
Among novel pharmaceutical dosage forms of analgesics, whose number and diversity are continuously increasing over the past two decades, of particular importance are transdermal opioid analgesics (fentanyl, buprenorphine) ...
Etiology and patogenesis of ischemic heart disease / Etiologija i patogeneza ishemijske bolesti srca
(Savez farmaceutskih udruženja Srbije, Beograd, 2008)
Ischemic heart disease (IHD) is a condition in which there is an inadequate supply of blood and oxygen to a portion of the myocardium; it typically occurs when there is an imbalance between myocardial oxygen supply and ...
3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists / 3D-QSAR modelovanje i analiza farmakofore antagonista serotoninskih 5-HT2A receptora
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
Creation of a statistically reliable 3D-QSAR (Quantitative Structure Activity Relationships) model enables definition of the structure of the pharmacophore for antagonists of serotonin 5-HT2A receptors and selection of the ...
Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients / Matriks metaloproteinaze-9 i tkivni inhibitori matriks metaloproteinaza-1 kod pacijenata sa sarkoidozom
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
Matrix metaloproteinases (MMPs) and their specific inhibitors - tissue inhibitors of matrix metalloproteinases (TIMPs) play an important role in pulmonary extracellular matrix destruction. Sarcoidosis is an inflammatory ...
Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules / Ispitivanje stabilnosti oralnih suspenzija omeprazola za pedijatrijsku primenu magistralno izrađenih iz omeprazol kapsula
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
In this paper, a study exploring the stability of omeprazole in pediatric suspensions is presented. In order to determine the most suitable suspension, three different formulations were prepared and stored under refrigerated ...
Penetration and permeation of corticosteroids from pharmaceutical preparations for the skin application / Penetracija i permeacija kortikosteroida iz farmaceutskih preparata za primenu na kožu
(Savez farmaceutskih udruženja Srbije, Beograd, 2008)
As corticosteroids (CS) represent large and significant group of dermatological drugs with a number of indications, performing of in vitro and/or in vivo penetration/permeation studies is of a paramount importance in ...
Resistin, inflammation and dyslipidemia in obese children and adolescents / Rezistin, inflamacija i dislipidemija kod gojazne dece i adolescenata
(Savez farmaceutskih udruženja Srbije, Beograd, 2015)
Introduction: Childhood obesity is related to cardiovascular diseases and diabetes mellitus type 2 in later life. Resistin, an adipokine primarily secreted by monocytes and tissue macrophages in humans, is considered to ...
Antidepressants and anxiolytics: Novel tablet formulations / Antidepresivi i anksiolitici - novine u formulaciji tableta
(Savez farmaceutskih udruženja Srbije, Beograd, 2007)
Development of new dosage forms with uncompromised efficacy, safety and stability and improved tolerability and dosage regimen that would result in better patient compliance is an imperative in modern pharmacotherapy. ...